Association between incident cancer and Guillain-Barré syndrome development: a nationwide case-control study
LS Levison, RW Thomsen, SH Sindrup, H Andersen - Neurology, 2022 - AAN Enterprises
Background and Objectives Cancer may increase the risk of developing Guillain-Barré
syndrome (GBS) due to molecular mimicry or immunosuppression, but the exact relationship …
syndrome (GBS) due to molecular mimicry or immunosuppression, but the exact relationship …
Malignancy in Guillain-Barré syndrome: a twelve-year single-center study
FL Hiew, YA Rajabally - Journal of the Neurological sciences, 2017 - Elsevier
Abstract The relationship between Guillain-Barré syndrome (GBS) and malignancy is
uncertain. We retrospectively analyzed data of 118 consecutive patients admitted with GBS …
uncertain. We retrospectively analyzed data of 118 consecutive patients admitted with GBS …
Guillain-Barré syndrome as a paraneoplastic manifestation of disseminated squamous cell carcinoma
V Navani, D Webster, SK Williams, D Agranoff - Case Reports, 2013 - casereports.bmj.com
We describe a 65-year-old woman who developed ascending, symmetrical paraesthesia
and weakness. This was on a background of metastatic disseminated squamous cell …
and weakness. This was on a background of metastatic disseminated squamous cell …
[HTML][HTML] A hepatic cancer patient with Guillain-Barre syndrome during the perioperative period of partial hepatectomy: a case report
SD Zeng, B Ye, ZJ Liang - International Journal of Clinical and …, 2015 - ncbi.nlm.nih.gov
A hepatic cancer patient with Guillain-Barré syndrome during the perioperative period of partial
hepatectomy: a case report - PMC Back to Top Skip to main content NIH NLM Logo Access keys …
hepatectomy: a case report - PMC Back to Top Skip to main content NIH NLM Logo Access keys …
Guillain-Barre syndrome?: 2 case reports
S Vatandoust - Reactions, 2012 - Springer
A 51-year-old man with stage III colon cancer began receiving trebananib [AMG 386] in
combination with folinic acid, fluorouracil and irinotecan (FOLFIRI). In September 2009, after …
combination with folinic acid, fluorouracil and irinotecan (FOLFIRI). In September 2009, after …